The therapeutic potential of umbilical cord mesenchymal stem cells in mice premature ovarian failure

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Wang, Shufang ^a   Yu, Ling ^a   Sun, Min ^b   Mu, Sha ^a   Wang, Changyong ^c   Wang, Deqing ^a   Yao, Yuanqing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

SEX HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; CUMULUS CELL; FEMALE; GRANULOSA CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY FOLLICLE CELL; OVARY FUNCTION; OVULATION; PREMATURE OVARIAN FAILURE; PROTEIN EXPRESSION; UMBILICAL CORD MESENCHYMAL STEM CELL TRANSPLANTATION; WILD TYPE; ANIMAL; FEASIBILITY STUDY; INSTITUTE FOR CANCER RESEARCH MOUSE; OVARY; PATHOPHYSIOLOGY; PRIMARY OVARIAN INSUFFICIENCY; PROCEDURES; TREATMENT OUTCOME; METHODOLOGY;

ANIMALS; CORD BLOOD STEM CELL TRANSPLANTATION; FEASIBILITY STUDIES; FEMALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED ICR; OVARY; OVULATION; PRIMARY OVARIAN INSUFFICIENCY; TREATMENT OUTCOME;

EID: 84884217047     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/690491     Document Type: Article

References (42)

1. Panay N., Fenton A., Premature ovarian failure: a growing concern. Climacteric 2008 11 1 1 3 2-s2.0-38349061597 10.1080/13697130701878635
2. Shelling M. L., Kirsner R. S., Failure to counsel patients with psoriasis to decrease alcohol consumption (and smoking). Archives of Dermatology 2010 146 12 1370 2-s2.0-78650432080 10.1001/archdermatol.2010.373
3. Wilson C., Autoimmunity: autoimmune Addison disease and premature ovarian failure. Nature Reviews Endocrinology 2011 7 9 498 2-s2.0-80052052443 10.1038/nrendo.2011.117
4. Hoyer P. B., Sipes I. G., Assessment of follicle destruction in chemical-induced ovarian toxicity. Annual Review of Pharmacology and Toxicology 1996 36 307 331 2-s2.0-0029892634
5. Woad K. J., Watkins W. J., Prendergast D., Shelling A. N., The genetic basis of premature ovarian failure. Australian and New Zealand Journal of Obstetrics and Gynaecology 2006 46 3 242 244 2-s2.0-33745964905 10.1111/j.1479-828X.2006.00585.x
6. Kalu E., Panay N., Spontaneous premature ovarian failure: management challenges. Gynecological Endocrinology 2008 24 5 273 279 2-s2.0-45949098864 10.1080/09513590801990764
7. Chen H., Li J., Cui T., Hu L., Adjuvant gonadotropin-releasing hormone analogues for the prevention of chemotherapy induced premature ovarian failure in premenopausal women. Cochrane Database of Systematic Reviews 2011 11 2-s2.0-77950180314 10.1002/14651858.CD008018 CD008018
8. Ginsburg J., Isaacs A. J., Gore M. B. R., Harvard C. W. H., Use of clomiphene and luteinizing hormone/follicle stimulating hormone releasing hormone in investigation of ovulatory failure. British Medical Journal 1975 3 5976 130 133 2-s2.0-0016680201
9. Pittenger M. F., Mackay A. M., Beck S. C., Jaiswal R. K., Douglas R., Mosca J. D., Moorman M. A., Simonetti D. W., Craig S., Marshak D. R., Multilineage potential of adult human mesenchymal stem cells. Science 1999 284 5411 143 147 2-s2.0-0033515827 10.1126/science.284.5411.143
10. Forraz N., Mcguckin C. P., The umbilical cord: a rich and ethical stem cell source to advance regenerative medicine. Cell Proliferation 2011 44 supplement 1 60 69 2-s2.0-79953865882 10.1111/j.1365-2184.2010.00729.x
11. Anzalone R., Iacono M. L., Corrao S., Magno F., Loria T., Cappello F., Zummo G., Farina F., La Rocca G., New emerging potentials for human wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells and Development 2010 19 4 423 438 2-s2.0-77950603767 10.1089/scd.2009.0299
12. Shang A.-J., Hong S.-Q., Xu Q., Wang H.-Y., Yang Y., Wang Z.-F., Xu B.-N., Jiang X.-D., Xu R.-X., NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain Research 2011 1391 102 113 2-s2.0-79955631432 10.1016/j.brainres. 2011.03.019
13. Liao W., Xie J., Zhong J., Liu Y., Du L., Zhou B., Xu J., Liu P., Yang S., Wang J., Han Z., Han Z. C., Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 2009 87 3 350 359 2-s2.0-61849179668 10.1097/TP.0b013e318195742e
14. Tipnis S., Viswanathan C., Majumdar A. S., Immunosuppressive properties of human umbilical cord-derived mesenchymal stem cells: role of B7-H1 and IDO. Immunology and Cell Biology 2010 88 8 795 806 2-s2.0-78649333063 10.1038/icb.2010.47
15. Guo J., Yang J., Cao G., Fan H., Guo C., Ma Y.-E., Qian Y., Chen L., Li X., Chang C., Xenogeneic immunosuppression of human umbilical cord mesenchymal stem cells in a major histocompatibility complex-mismatched allogeneic acute graft-versus-host disease murine model. European Journal of Haematology 2011 87 3 235 243 2-s2.0-84860413570 10.1111/j.1600-0609.2011.01635.x
16. Ishige I., Nagamura-Inoue T., Honda M. J., Harnprasopwat R., Kido M., Sugimoto M., Nakauchi H., Tojo A., Comparison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. International Journal of Hematology 2009 90 2 261 269 2-s2.0-70350571657 10.1007/s12185-009-0377-3
17. Zhou S., From bone to brain: human skeletal stem cell therapy for stroke. Central Nervous System Agents in Medicinal Chemistry 2011 11 2 157 163 2-s2.0-79959313482
18. Liu Y., Teoh S. H., Chong M. S., Lee E. S., Mattar C. N., Randhawa N. K., Vasculogenic and osteogenesis-enhancing potential of human umbilical cord blood endothelial colony-forming cells. Stem Cells 2012 30 1911 1924
19. Moodley A., Guardabassi L., Clonal spread of methicillin-resistant coagulase-negative staphylococci among horses, personnel and environmental sites at equine facilities. Veterinary Microbiology 2009 137 3-4 397 401 2-s2.0-67349240859 10.1016/j.vetmic.2009.01.034
20. Batsali A. K., Kastrinaki M. C., Papadaki H. A., Pontikoglou C., Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications. Current Stem Cell Research and Therapy 2013 8 144 155
21. McGuirk S., Fahy C., Costi D., Cyna A. M., Use of invasive placebos in research on local anaesthetic interventions. Anaesthesia 2011 66 2 84 91 2-s2.0-79251642768 10.1111/j.1365-2044.2010.06560.x
22. Fu X., He Y., Xie C., Liu W., Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy 2008 10 4 353 363 2-s2.0-47249110686 10.1080/14653240802035926
23. Lee H.-J., Selesniemi K., Niikura Y., Niikura T., Klein R., Dombkowski D. M., Tilly J. L., Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. Journal of Clinical Oncology 2007 25 22 3198 3204 2-s2.0-34247549003 10.1200/JCO.2006.10.3028
24. Nekanti U., Rao V. B., Bahirvani A. G., Jan M., Totey S., Ta M., Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells and Development 2010 19 1 117 130 2-s2.0-75749109723 10.1089/scd.2009.0177
25. Park J. H., Hwang I., Hwang S. H., Han H., Ha H., Human umbilical cord blood-derived mesenchymal stem cells prevent diabetic renal injury through paracrine action. Diabetes Research and Clinical Practice 2012 98 465 473
26. Latifpour M., Nematollahi-Mahani S. N., Deilamy M., Azimzadeh B. S., Eftekhar-Vaghefi S. H., Nabipour F., Najafipour H., Nakhaee N., Yaghoubi M., Eftekhar-Vaghefi R., Salehinejad P., Azizi H., Improvement in cardiac function following transplantation of human umbilical cord matrix-derived mesenchymal cells. Cardiology 2011 120 1 9 18 2-s2.0-80855133013 10.1159/000332581
27. Chang Y. S., Choi S. J., Ahn S. Y., Sung D. K., Sung S. I., Yoo H. S., Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLoS ONE 2013 8 e52419
28. Vergnes L., Phan J., Stolz A., Reue K., A cluster of eight hydroxysteroid dehydrogenase genes belonging to the aldo-keto reductase supergene family on mouse chromosome 13. Journal of Lipid Research 2003 44 3 503 511 2-s2.0-0037606195 10.1194/jlr.M200399-JLR200
29. Gamwell L. F., Collins O., Vanderhyden B. C., The mouse ovarian surface epithelium contains a population of LY6A (SCA-1) expressing progenitor cells that are regulated by ovulation-associated factors. Biology of Reproduction 2012 87 4 10. 1095/biolreprod. 112. 100347
30. Prins J. B., Williamson K. A., Kamp M. M., Van Hezik E. J., Vander Kwast T. H., Hagemeijer A., The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma. International Journal of Cancer 1998 75 649 653
31. Nabhan S. K., Bitencourt M. A., Duval M., Abecasis M., Dufour C., Boudjedir K., Rocha V., Socié G., Passweg J., Goi K., Sanders J., Snowden J., Yabe H., Pasquini R., Gluckman E., Fertility recovery and pregnancy after allogeneic hematopoietic stem cell transplantation in Fanconi anemia patients. Haematologica 2010 95 10 1783 1787 2-s2.0-77957771805 10.3324/haematol.2010. 023929
32. Daldrup-Link H. E., Rudelius M., Oostendorp R. A. J., Jacobs V. R., Simon G. H., Gooding C., Rummeny E. J., Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Academic Radiology 2005 12 4 502 510 2-s2.0-17044428616 10.1016/j.acra.2004.12. 021
33. Ling B., Feng D. Q., Zhou Y., Gao T., Wei H. M., Tian Z. G., Effect of conditioned medium of mesenchymal stem cells on the in vitro maturation and subsequent development of mouse oocyte. Brazilian Journal of Medical and Biological Research 2008 41 11 978 985 2-s2.0-59849112613
34. Hung T.-H., Hsieh C.-C., Hsu J.-J., Lo L.-M., Chiu T.-H., Hsieh T.-T., Risk factors for placental abruption in an Asian population. Reproductive Sciences 2007 14 1 59 65 2-s2.0-34648846618 10.1177/1933719106298363
35. Hocking J. C., Hehr C. L., Bertolesi G. E., Wu J. Y., McFarlane S., Distinct roles for Robo2 in the regulation of axon and dendrite growth by retinal ganglion cells. Mechanisms of Development 2010 127 1-2 36 48 2-s2.0-73649101691 10.1016/j.mod.2009.11.002
36. Lin P., Correa D., Lin Y., Caplan A. I., Polybrene inhibits human mesenchymal stem cell proliferation during lentiviral transduction. PLoS ONE 2011 6 8 2-s2.0-80052074191 10.1371/journal.pone.0023891 e23891
37. Park D.-H., Eve D. J., Chung Y.-G., Sanberg P. R., Regenerative medicine for neurological disorders. The Scientific World Journal 2010 10 470 489 2-s2.0-77951729962 10.1100/tsw.2010.39
38. Souidi N., Stolk M., Seifert M., Ischemia-reperfusion injury: beneficial effects of mesenchymal stromal cells. Current Opinion in Organ Transplantation 2013 18 34 43
39. Lin H., Xu R., Zhang Z., Chen L., Shi M., Wang F.-S., Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases. Cellular and Molecular Immunology 2011 8 1 19 22 2-s2.0-79952460157 10.1038/cmi.2010.57
40. Yan Y., Xu W., Qian H., Si Y., Zhu W., Cao H., Zhou H., Mao F., Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver International 2009 29 3 356 365 2-s2.0-59849123877 10.1111/j.1478-3231.2008.01855.x
41. Weiss M. L., Anderson C., Medicetty S., Seshareddy K. B., Weiss R. J., VanderWerff I., Troyer D., McIntosh K. R., Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008 26 11 2865 2874 2-s2.0-56249139741 10.1634/stemcells.2007-1028
42. Weiss M. L., Medicetty S., Bledsoe A. R., Rachakatla R. S., Choi M., Merchav S., Luo Y., Rao M. S., Velagaleti G., Troyer D., Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006 24 3 781 792 2-s2.0-33744973827 10.1634/stemcells.2005-0330